MedPath

Effect of repeated paravertebral injections with local anesthetics and steroids on prevention of post-herpetic neuralgia

Not Applicable
Completed
Conditions
chest wall herpetic eruption
post-herpetic neuralgia
Anaesthesiology - Pain management
Infection - Other infectious diseases
Registration Number
ACTRN12614000377639
Lead Sponsor
Mohamed Y. Makharita
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
75
Inclusion Criteria

patients over 50 who had chest wall herpetic eruption of less than one week, with moderate and severe pain and received appropriate antiviral therapy.

Exclusion Criteria

patient refusal, eruption of more than one week duration, patients who did not receive appropriate antiviral therapy, patients with mild pain, heavy skin eruption (no healthy area for needle entry) and infection at site of injection. Patients with history of renal, hepatic diseases, coagulopathy, diabetes, steroid therapy, malignancies and patients taking chemo and/or radiotherapy will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Lower the incidence of post herpetic neuralgia which will be evaluated by visual analogue scale[ Assessed before the block (basal), 1 hour after the block, every 3 days for 2 weeks after the procedure and every week for 6 weeks and after 3 and 6 months. ]
Secondary Outcome Measures
NameTimeMethod
Pain severity was assessed using Visual Analogue Scale (VAS), (10 cm unmarked line in which 0 = no pain and 10 cm=worst pain imaginable[Before the block (basal), 1 hour after the block, every 3 days for 2 weeks after the procedure and every week for 6 weeks and after 3 and 6 months];Analgesic consumption was assessed by patient self-report[Before the block (basal), 1 hour after the block, every 3 days for 2 weeks after the procedure and every week for 6 weeks and after 3 and 6 months]
© Copyright 2025. All Rights Reserved by MedPath